Tyr185
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Phosphorylation Site Page:
Tyr185 - ERK2 (rat)

Site Information
HTGFLTEyVATRWYR    SwissProt Entrez-Gene
Predicted information: Scansite
Orthologous residues: ERK2 (human): Y187, ERK2 (mouse): Y185, ERK2 (chicken): Y195
Blast this site against: NCBI  SwissProt  PDB 
Available spectra:  1 CST

In vivo Characterization
Methods used to characterize site in vivo: [32P] bio-synthetic labeling (379), electrophoretic mobility shift (305), flow cytometry (354), immunoprecipitation (6, 176, 245, 265, 353), mass spectrometry (231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256, 257, 261, 262, 263, 264, 267, 268, 269, 270, 271, 272, 273, 274, 276, 277, 278, 279, 308, 323, 324, 325, 330, 331), mutation of modification site (258, 266, 293, 302, 347, 351, 379), phospho-antibody (1, 3, 4, 5, 6, 11, 13, 14, 15, 16, 17, 18, 19, 20, 24, 25, 26, 27, 28, 29, 30, 52, 53, 176, 177, 178, 179, 227, 228, 229, 230, 241, 242, 243, 245, 258, 259, 260, 265, 266, 275, 280, 281, 283, 284, 285, 286, 287, 288, 289, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 306, 307, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 326, 327, 328, 329, 332, 333, 334, 335, 336, 337, 338, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 355, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 371, 372, 373, 374, 375, 376, 377, 378, 380, 381, 382, 383, 384), western blotting (1, 3, 4, 5, 6, 11, 13, 14, 15, 16, 17, 18, 19, 20, 24, 25, 26, 27, 28, 29, 30, 52, 53, 176, 177, 178, 179, 227, 228, 230, 241, 242, 243, 245, 258, 259, 260, 265, 266, 275, 280, 281, 283, 284, 285, 286, 287, 288, 289, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 306, 307, 309, 311, 312, 313, 314, 315, 320, 321, 326, 327, 328, 329, 332, 335, 337, 338, 340, 341, 345, 346, 347, 348, 349, 350, 351, 353, 354, 355, 356, 357, 358, 359, 360, 361, 362, 364, 365, 366, 367, 369, 371, 374, 375, 376, 377, 382, 383, 384)
Disease tissue studied: Alzheimer's disease (319), adrenal cancer (260, 293, 306, 358, 360, 364, 382), pheochromocytoma (260, 293, 306, 358, 360, 364, 382), bone cancer (337, 361), brain cancer (258), glioma (258), colorectal cancer (287), colorectal carcinoma (287), liver cancer (312, 349, 375), pancreatic cancer (353, 365), pancreatic carcinoma (353, 365), diabetes mellitus (6)
Relevant cell line - cell type - tissue: 'brain, amygdala' (3, 229), 'brain, caudate-putamen' (229), 'brain, cerebral cortex' (52, 229, 296, 372), 'brain, forebrain' (372), 'brain, hippocampus' (3, 30, 229, 300, 320, 332, 372, 373), 'brain, hippocampus, dentate gyrus' (243, 347), 'brain, hypothalamus' (3), 'brain, nucleus accumbens' (229), 'brain, striatum' (52, 300, 326), 'brain, ventral tegmental area' (229), 'granulosa, luteal' (366), 'kidney, inner medulla' (308), 'muscle, skeletal' (25, 340, 344, 357, 359), 'muscle, smooth' (20, 374), 'muscle, smooth'-'heart, artery' (24, 280), 'muscle, smooth'-thoracic aorta (336, 348), 'neuron, cerebellar granule'-brain (178, 319), 'neuron, cortical' (14, 355), 'neuron, cortical'-brain (29, 289, 329), 'neuron, hippocampal'-'brain, embryonic' (14), 'neuron, hippocampal'-brain (29, 350, 363), 293 (epithelial) (176, 242, 307, 379), 3T3 (fibroblast) (302), 3T3-L1 (fibroblast) (177, 312), A7r5 ('muscle, smooth') (376), adipocyte (286, 299), adipocyte-adipose tissue (321), adipose tissue (341), beta-pancreas (15, 19), brain (231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 251, 252, 253, 254, 255, 256, 323, 324, 325, 330, 331), C2C12 (myoblast) (275), C6 (glial) (258), COS (fibroblast) (4, 345, 356), epithelial-'kidney, tubule' (1), fibroblast-heart (259, 305), GEC (epithelial) (318, 380), GG-CL (ovarian) (17), GH4C1 (pituitary cell) (265), GN4 (epithelial) (342), granulosa (316), H-35 (hepatic) (375), H4IIe (hepatic) (349), H9c2 (myoblast) (177, 291), heart (241, 242), HeLa (cervical) (16), hepatocyte (314), HepG2 (hepatic) (312), HIRcB (fibroblast) (177, 179), HIT (pancreatic) (333), IEC-18 (epithelial) (287), IEC-6 (epithelial) (303, 369), INS-1 (pancreatic) (353, 365), L6 (myoblast) (53, 230, 312), liver (298, 311, 335), lung (11), M059J (glial) (283), MEF (fibroblast) (266, 283), myocardium (304), myocyte (376), myocyte-heart (227, 242, 245, 259, 275, 281, 327, 351, 354), myometrial (315), neuron-'brain, cerebral cortex' (297, 306), neuron-'brain, hippocampus' (28, 310, 313, 377), neuron-'brain, hypothalamus' (362), neuron-spinal cord (295), neuron:synaptosome-'brain, cerebral cortex' (5), NRK (fibroblast) (383), pancreatic acini (288), PC-12 (chromaffin) (246, 247, 248, 249, 250, 257, 260, 261, 262, 263, 264, 267, 268, 269, 270, 271, 272, 273, 274, 276, 277, 278, 279, 293, 306, 322, 334, 358, 360, 364, 381, 382, 384), R22 ('muscle, smooth') (266), Rat1 (fibroblast) (177, 283), Rat2 (fibroblast) [TrkB (rat)] (309), RBL-2H3 (basophil) (228, 352, 371, 378), RBL-2H3 (basophil) [transfection] (27), REF52 (fibroblast) (285, 345), RIE (epithelial) (284, 301), RIE (epithelial) [PPAR-gamma (mouse)] (301), RIN (epithelial) (333, 338), RM-4 (mesothelial) (343), ROS 17/2.8 (bone cell) (337), spinal cord (13), SYF (fibroblast) (266), T84 (intestinal) (287), UMR106 (bone cell) (361), vascular (6), vascular smooth muscle cell ('muscle, smooth') (266, 292, 294, 307, 367, 368), VSMC (6, 18), VSMC ('muscle, smooth') (26), VSMC-aorta (317), WB-F344 (epithelial) (328)

Controlled by
Regulatory protein: CALB1 (rat) (313), Caveolin-2 (rat) (179), DISC1 (human) (297), DYN1 (rat) (18), EEA1 (rat) (18), EGFR (human) (380), FAK (mouse) (374), FAK (rat) (20, 245), HER2 (rat) (6), HRas (human) (318, 342), ITGA5 (human) (284), KRas (rat) (369), LEPR (mouse) (333), Lyn (rat) (27), MEK1 (rat) (351), NDST1 (human) (20), PAK1 (rat) (301), PKCA (rat) (318), PKCD (human) (258), PKCD (rat) (258), PKCE (rat) (260), PPAR-gamma (mouse) (301), PPP1R14A (rat) (302), prolactin (human) (3), PTP-SL (human) (360), PXN (rat) (15), Pyk2 (rat) (28), Rap2A (human) (320), RhoA (human) (318), SH2-B-beta (rat) (370), SHP-2 (rat) (245, 309)
Putative upstream kinases: MEK1 (rat) (285)
Kinases, in vitro: MEK1 (human) (242, 379), MEK1 (rat) (285)
Putative upstream phosphatases: DUPD1 (rat) (17), PPP2CB (rat) (290)
Phosphatases, in vitro: DUPD1 (rat) (17)
Treatments: 1400W (317), 17-beta-estradiol (14), 2,2'-DCB (315), 4-AP (5, 329), 4-methycatechol (355), A23187 (352), AEBSF (317), AG1478 (259, 266, 303, 305, 328, 336, 369, 380), AG490 (17), AG825 (6), AICAR (316), angiopoietin-1 (327), angiopoietin-2 (327), angiotensin (307), angiotensin 2 (18, 24, 26, 242, 287, 305, 317), anisomycin (384), anoxia (319), anthrax toxin (383), anti-CD29 (343), anti-FcR1 (27), antigenic stimulation (228), APV (347, 377), asbestos (343), aspirin (228), azaserine (338), BAPTA-AM (26, 366), BDNF (29, 52, 306, 309, 355), berberine (5, 25), beta-amyloid 42 (14), betacellulin (336), bicuculline (329, 350), bisindolylmaleimide (260), BIX02188 (13), BMP2 (381), bradykinin (299), C5b-7 (380), C5b-9 (318), caffeine (296), cAMP analog (334), carbachol (242), cell adhesion (314), CGS 21680 (358), cholecystokinin (288), ciglitazone (342), Clostridium lethal toxin (371), Clostridium toxin B (371), cobalt (260), CPCCOEt (300), culturing of cells (289, 311), CV11974 (317), cyclic stretch (245, 281), cycloheximide (355), depolarization (29, 332, 362), DFMO (303), DHPG (300, 326), DNP (378), doxorubicin (328), DPI (317), ebselen (317), EGF (176, 244, 259, 285, 287, 293, 303, 305, 314, 318, 334, 345, 356, 360, 361, 365, 379, 380), electrical stimulation (296, 347), endothelin (354), estrogen (286), ethyl pyruvate (11), etoposide (258), exendin-4 (19), exercise (373), Fas (6), FGF2 (380), fibronectin (285, 345), forskolin (334, 362, 377), FSH (316), GABA (362), gefitinib (342), genistein (376), GF109203X (259, 287, 332), glucosamine (338), glucose (15, 338, 365), glucose starvation (282), glycine (350), Go 6976 (26, 259), gomisin A (16), gomisin N (16), GRGDSP (343), H-7 (306), H-89 (286, 314, 334), H2O2 (259, 305), heart failure (241), hemorrhage (335), heparin (20), herbimycin A (376), heroin withdrawal (229), HGF (351, 380), high glucose (6), hyperglycemia (372), hypoxia (382), IBMX (334), IGF-1 (316, 365), IL-1b (292), IL-6 (375), insulin (177, 179, 230, 282, 291, 299, 304, 312, 321, 349, 367, 375), interstitial flow (20), ischemia/reperfusion (243, 311, 372), isoproterenol (305), JNK inhibitor I (338), K252a (306, 355), kainic acid (310), KCl (376, 377), L-NAME (317), laminin-1 (327), leptin (333), LIF (375), long-term potentiation (14, 347), LPA (287), LPS (11), LY294002 (29, 52, 283, 301, 311, 354, 368, 369), lysophosphatidylcholine (367), mechanical stress (337), metformin (312), MG132 (350), MPEP (300), MPP+ (178), muscimol (362), muscle atrophy (344, 359), myricetin (317), NAC (260, 342), nafenopin (342), naltrexone (229), neuregulin (241, 242), NGF (293, 306, 322, 334, 358, 364, 370, 381, 382, 384), nimodipine (377), NMDA (28, 377), norepinephrine (259), NS 1231 (364), NSC 663284 (17), NSC 95397 (17), NT3 (4), okadaic acid (4, 17, 326), oncostatin M (375), ouabain (376), PAF (30), Pasteurella multocida toxin (259, 305), PCP (52), PD123319 (317), PD153035 (342), PD169316 (340), PD184352 (26, 339), PD98059 (4, 5, 6, 15, 52, 178, 282, 288, 292, 311, 332, 340, 351, 354, 355, 358, 361, 367, 369, 374, 383, 384), PDGF (26, 280, 283, 368, 374), peptide agonist (346), PF-228 (20), PGE2a (366), phenylephrine (242), phorbol ester (259, 287, 305, 318, 378, 380), pleiotrophin (275), PP1 (227, 305), PP2 (19, 245, 314, 326, 332, 334, 342, 345), PP3 (332, 342), PRL (17), PTH (361), PTP1B inhibitor (17), PTX (305), PTZ (310), putrescine (303), rapamycin (29, 230, 282, 283, 312, 321), resveratrol (348), RGDS (343), Ro31-8220 (287), roscovitine (306), SB202190 (311), SB203580 (311, 339, 354, 384), serum (1, 318, 348, 380), SHP2 inhibitor (17), siRNA (17, 245, 258, 260, 297, 302, 307), sorbitol (339), SP600125 (340, 354), spermine (303), SSA412 (227), SU6656 (243, 280), TeTx (178), TGF-alpha (365), TGF-beta (266, 363), thrombin (259, 305, 368), TNF (16, 340), TNP-OVA (371), TRAIL (258), trauma (335), TRH (265), troglitazone (342), TTX (350), U0126 (1, 4, 26, 29, 177, 243, 259, 265, 266, 286, 287, 288, 291, 292, 293, 301, 305, 306, 307, 316, 317, 321, 326, 328, 329, 332, 342, 349, 354, 363, 375), UV (339, 382), vanadate (311), VEGF (311), vitronectin (327), W-7 (366), wortmannin (177, 178, 282, 286, 306, 321, 371), Y27632 (266, 318), Zn(2+) (260)

Downstream Regulation
Effects of modification on ERK2: activity, induced (343, 362, 373), enzymatic activity, induced (310, 381), intracellular localization (15, 179, 362), molecular association, regulation (379)
Effects of modification on biological processes: cell growth, altered (243)
Induce interaction with: MEK1 (human) (379)

Disease / Diagnostics Relevance
Relevant diseases: major depressive disorder (297)

References

1

Mouawad F, et al. (2014) Role of Guanine Nucleotide Exchange Factor-H1 in Complement-mediated RhoA Activation in Glomerular Epithelial Cells. J Biol Chem 289, 4206-18
24356971   Curated Info

2

Miranda CA, Lee JW, Chou CL, Knepper MA (2014) Tolvaptan as a tool in renal physiology. Am J Physiol Renal Physiol 306, F359-66
24305472   Curated Info

3

Morales T, Lorenson M, Walker AM, Ramos E (2014) Both prolactin (PRL) and a molecular mimic of phosphorylated PRL, S179D-PRL, protect the hippocampus of female rats against excitotoxicity. Neuroscience 258, 211-7
24252319   Curated Info

4

Funahashi Y, et al. (2013) ERK2-Mediated Phosphorylation of Par3 Regulates Neuronal Polarization. J Neurosci 33, 13270-85
23946386   Curated Info

5

Lin TY, et al. (2013) Berberine Inhibits the Release of Glutamate in Nerve Terminals from Rat Cerebral Cortex. PLoS One 8, e67215
23840629   Curated Info

6

Akhtar S, et al. (2013) Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction. PLoS One 8, e67813
23826343   Curated Info

7

Jun HJ, et al. (2012) The oncogenic lung cancer fusion kinase CD74-ROS activates a novel invasiveness pathway through E-Syt1 phosphorylation. Cancer Res 72, 3764-74
22659450   Curated Info

8

Damiano L, et al. (2012) p140Cap suppresses the invasive properties of highly metastatic MTLn3-EGFR cells via impaired cortactin phosphorylation. Oncogene 31, 624-33
21725361   Curated Info

9

Andreu-Pérez P, et al. (2011) Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF. Sci Signal 4, ra58
21917714   Curated Info

10

Flinder LI, et al. (2011) EGF-induced ERK-activation downstream of FAK requires rac1-NADPH oxidase. J Cell Physiol 226, 2267-78
21660950   Curated Info

11

Kung CW, et al. (2011) Ethyl pyruvate reduces acute lung injury via regulation of iNOS and HO-1 expression in endotoxemic rats. J Surg Res 167, e323-31
21324485   Curated Info

12

Angelone T, et al. (2011) Distinct signalling mechanisms are involved in the dissimilar myocardial and coronary effects elicited by quercetin and myricetin, two red wine flavonols. Nutr Metab Cardiovasc Dis 21, 362-71
20096547   Curated Info

13

Wang CG, et al. (2011) Activation of the spinal extracellular signal-regulated kinase 5 signaling pathway contributes to morphine physical dependence in rats. Neurosci Lett 494, 38-43
21356274   Curated Info

14

Logan SM, Sarkar SN, Zhang Z, Simpkins JW (2011) Estrogen-induced signaling attenuates soluble Aβ peptide-mediated dysfunction of pathways in synaptic plasticity. Brain Res 1383, 1-12
21262203   Curated Info

15

Rondas D, Tomas A, Halban PA (2011) Focal adhesion remodeling is crucial for glucose-stimulated insulin secretion and involves activation of focal adhesion kinase and paxillin. Diabetes 60, 1146-57
21357465   Curated Info

16

Waiwut P, et al. (2011) Gomisin N enhances TNF-α-induced apoptosis via inhibition of the NF-κB and EGFR survival pathways. Mol Cell Biochem 350, 169-75
21188622   Curated Info

17

Devi YS, et al. (2011) Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. J Biol Chem 286, 7609-18
21199871   Curated Info

18

Nazarewicz RR, et al. (2011) Early endosomal antigen 1 (EEA1) is an obligate scaffold for angiotensin II-induced, PKC-alpha-dependent Akt activation in endosomes. J Biol Chem 286, 2886-95
21097843   Curated Info

19

Mukai E, et al. (2011) Exendin-4 suppresses SRC activation and reactive oxygen species production in diabetic Goto-Kakizaki rat islets in an Epac-dependent manner. Diabetes 60, 218-26
20978090   Curated Info

20

Shi ZD, Wang H, Tarbell JM (2011) Heparan sulfate proteoglycans mediate interstitial flow mechanotransduction regulating MMP-13 expression and cell motility via FAK-ERK in 3D collagen. PLoS One 6, e15956
21246051   Curated Info

21

Dupont E, et al. (2011) ERK is involved in the reorganization of somatosensory cortical maps in adult rats submitted to hindlimb unloading. PLoS One 6, e17564
21408155   Curated Info

22

Zhou L, Too HP (2011) Mitochondrial localized STAT3 is involved in NGF induced neurite outgrowth. PLoS One 6, e21680
21738764   Curated Info

23

Trinko R, et al. (2011) Erk1/2 mediates leptin receptor signaling in the ventral tegmental area. PLoS One 6, e27180
22076135   Curated Info

24

Koshman YE, et al. (2010) FRNK inhibition of focal adhesion kinase-dependent signaling and migration in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 30, 2226-33
20705914   Curated Info

25

Ma X, et al. (2010) Berberine-induced activation of 5'-adenosine monophosphate-activated protein kinase and glucose transport in rat skeletal muscles. Metabolism 59, 1619-27
20423742   Curated Info

26

Doyon P, Servant MJ (2010) Tumor necrosis factor receptor-associated factor-6 and ribosomal S6 kinase intracellular pathways link the angiotensin II AT1 receptor to the phosphorylation and activation of the IkappaB kinase complex in vascular smooth muscle cells. J Biol Chem 285, 30708-18
20659889   Curated Info

27

Sanderson MP, et al. (2010) Syk and Lyn mediate distinct Syk phosphorylation events in FcɛRI-signal transduction: implications for regulation of IgE-mediated degranulation. Mol Immunol 48, 171-8
20828828   Curated Info

28

Hsin H, Kim MJ, Wang CF, Sheng M (2010) Proline-rich tyrosine kinase 2 regulates hippocampal long-term depression. J Neurosci 30, 11983-93
20826662   Curated Info

29

Zhou X, et al. (2010) Intracellular calcium and calmodulin link brain-derived neurotrophic factor to p70S6 kinase phosphorylation and dendritic protein synthesis. J Neurosci Res 88, 1420-32
20029971   Curated Info

30

Moriguchi S, Shioda N, Yamamoto Y, Fukunaga K (2010) Platelet-activating factor-induced synaptic facilitation is associated with increased calcium/calmodulin-dependent protein kinase II, protein kinase C and extracellular signal-regulated kinase activities in the rat hippocampal CA1 region. Neuroscience 166, 1158-66
20074623   Curated Info

31

(2010) CST Curation Set: 8873; Year: 2010; SILAC: N; Biosample/Treatment: ST-11-BL(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

32

(2010) CST Curation Set: 8874; Year: 2010; SILAC: N; Biosample/Treatment: ST-12-BL(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

33

(2010) CST Curation Set: 8877; Year: 2010; SILAC: N; Biosample/Treatment: XY2-ST-14-C(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

34

(2010) CST Curation Set: 8884; Year: 2010; SILAC: N; Biosample/Treatment: ST-25-BL(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

35

(2010) CST Curation Set: 8921; Year: 2010; SILAC: N; Biosample/Treatment: ST-31-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

36

(2010) CST Curation Set: 8931; Year: 2010; SILAC: N; Biosample/Treatment: ST-38-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

37

(2010) CST Curation Set: 8930; Year: 2010; SILAC: N; Biosample/Treatment: ST-38-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

38

(2010) CST Curation Set: 8870; Year: 2010; SILAC: N; Biosample/Treatment: ST-11-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

39

(2010) CST Curation Set: 8923; Year: 2010; SILAC: N; Biosample/Treatment: ST-32-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

40

(2010) CST Curation Set: 8885; Year: 2010; SILAC: N; Biosample/Treatment: ST-25-BL(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

41

(2010) CST Curation Set: 8919; Year: 2010; SILAC: N; Biosample/Treatment: XY2-ST-26-BL(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

42

(2010) CST Curation Set: 8878; Year: 2010; SILAC: N; Biosample/Treatment: ST-17-BL(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

43

(2010) CST Curation Set: 8918; Year: 2010; SILAC: N; Biosample/Treatment: XY2-ST-26-BL(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

44

(2010) CST Curation Set: 8871; Year: 2010; SILAC: N; Biosample/Treatment: ST-11-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

45

(2010) CST Curation Set: 8922; Year: 2010; SILAC: N; Biosample/Treatment: ST-32-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

46

(2010) CST Curation Set: 8868; Year: 2010; SILAC: N; Biosample/Treatment: ST-7-BL(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

47

(2010) CST Curation Set: 8875; Year: 2010; SILAC: N; Biosample/Treatment: ST-12-BL(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

48

(2010) CST Curation Set: 8872; Year: 2010; SILAC: N; Biosample/Treatment: ST-11-BL(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

49

(2010) CST Curation Set: 8920; Year: 2010; SILAC: N; Biosample/Treatment: ST-31-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

50

(2010) CST Curation Set: 8881; Year: 2010; SILAC: N; Biosample/Treatment: ST-24-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

51

(2010) CST Curation Set: 8880; Year: 2010; SILAC: N; Biosample/Treatment: ST-24-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

52

Xia Y, et al. (2010) Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K/Akt pathways. Neuropharmacology 58, 330-6
19887077   Curated Info

53

Csibi A, Communi D, Müller N, Bottari SP (2010) Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms. PLoS One 5, e10070
20383279   Curated Info

54

(2009) CST Curation Set: 8474; Year: 2009; SILAC: N; Biosample/Treatment: ST-5-BL(cell line)/untreated; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

55

(2009) CST Curation Set: 8473; Year: 2009; SILAC: N; Biosample/Treatment: ST-5-BL(cell line)/untreated; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

56

(2009) CST Curation Set: 8469; Year: 2009; SILAC: N; Biosample/Treatment: ST-38-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

57

(2009) CST Curation Set: 8470; Year: 2009; SILAC: N; Biosample/Treatment: ST-38-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

58

(2009) CST Curation Set: 8467; Year: 2009; SILAC: N; Biosample/Treatment: ST-31-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

59

(2009) CST Curation Set: 8468; Year: 2009; SILAC: N; Biosample/Treatment: ST-31-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

60

(2009) CST Curation Set: 8471; Year: 2009; SILAC: N; Biosample/Treatment: ST-38-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

61

(2009) CST Curation Set: 8463; Year: 2009; SILAC: N; Biosample/Treatment: ST-23-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

62

(2009) CST Curation Set: 8462; Year: 2009; SILAC: N; Biosample/Treatment: ST-23-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

63

(2009) CST Curation Set: 8460; Year: 2009; SILAC: N; Biosample/Treatment: ST-17-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

64

(2009) CST Curation Set: 8461; Year: 2009; SILAC: N; Biosample/Treatment: ST-23-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

65

(2009) CST Curation Set: 8459; Year: 2009; SILAC: N; Biosample/Treatment: ST-17-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

66

(2009) CST Curation Set: 8464; Year: 2009; SILAC: N; Biosample/Treatment: ST-23-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

67

(2009) CST Curation Set: 8448; Year: 2009; SILAC: N; Biosample/Treatment: ST-31-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

68

(2009) CST Curation Set: 8456; Year: 2009; SILAC: N; Biosample/Treatment: ST-17-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

69

(2009) CST Curation Set: 8447; Year: 2009; SILAC: N; Biosample/Treatment: ST-31-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

70

(2009) CST Curation Set: 8457; Year: 2009; SILAC: N; Biosample/Treatment: ST-11-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

71

(2009) CST Curation Set: 8455; Year: 2009; SILAC: N; Biosample/Treatment: ST-17-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

72

(2009) CST Curation Set: 8458; Year: 2009; SILAC: N; Biosample/Treatment: ST-11-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

73

(2009) CST Curation Set: 8445; Year: 2009; SILAC: N; Biosample/Treatment: ST-11-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

74

(2009) CST Curation Set: 8442; Year: 2009; SILAC: N; Biosample/Treatment: ST-12-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

75

(2009) CST Curation Set: 8446; Year: 2009; SILAC: N; Biosample/Treatment: ST-11-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

76

(2009) CST Curation Set: 8704; Year: 2009; SILAC: N; Biosample/Treatment: ST-40-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

77

(2009) CST Curation Set: 8702; Year: 2009; SILAC: N; Biosample/Treatment: ST-18-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

78

(2009) CST Curation Set: 8439; Year: 2009; SILAC: N; Biosample/Treatment: ST-6-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

79

(2009) CST Curation Set: 8441; Year: 2009; SILAC: N; Biosample/Treatment: ST-12-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

80

(2009) CST Curation Set: 8705; Year: 2009; SILAC: N; Biosample/Treatment: ST-40-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

81

(2009) CST Curation Set: 8440; Year: 2009; SILAC: N; Biosample/Treatment: ST-6-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

82

(2009) CST Curation Set: 8436; Year: 2009; SILAC: N; Biosample/Treatment: ST-6-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

83

(2009) CST Curation Set: 8437; Year: 2009; SILAC: N; Biosample/Treatment: ST-5-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

84

(2009) CST Curation Set: 8431; Year: 2009; SILAC: N; Biosample/Treatment: ST-23-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

85

(2009) CST Curation Set: 8438; Year: 2009; SILAC: N; Biosample/Treatment: ST-5-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

86

(2009) CST Curation Set: 8435; Year: 2009; SILAC: N; Biosample/Treatment: ST-6-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

87

(2009) CST Curation Set: 8432; Year: 2009; SILAC: N; Biosample/Treatment: ST-23-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

88

(2009) CST Curation Set: 8430; Year: 2009; SILAC: N; Biosample/Treatment: ST-38-Bl(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

89

(2009) CST Curation Set: 8429; Year: 2009; SILAC: N; Biosample/Treatment: ST-38-Bl(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

90

(2009) CST Curation Set: 8344; Year: 2009; SILAC: N; Biosample/Treatment: ST-25-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

91

(2009) CST Curation Set: 8343; Year: 2009; SILAC: N; Biosample/Treatment: ST-25-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

92

(2009) CST Curation Set: 8340; Year: 2009; SILAC: N; Biosample/Treatment: ST-19-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

93

(2009) CST Curation Set: 8337; Year: 2009; SILAC: N; Biosample/Treatment: ST-24-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

94

(2009) CST Curation Set: 8338; Year: 2009; SILAC: N; Biosample/Treatment: ST-24-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

95

(2009) CST Curation Set: 8339; Year: 2009; SILAC: N; Biosample/Treatment: ST-19-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

96

(2009) CST Curation Set: 8329; Year: 2009; SILAC: N; Biosample/Treatment: ST-7-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

97

(2009) CST Curation Set: 8331; Year: 2009; SILAC: N; Biosample/Treatment: ST-33-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

98

(2009) CST Curation Set: 8336; Year: 2009; SILAC: N; Biosample/Treatment: ST-32-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

99

(2009) CST Curation Set: 8332; Year: 2009; SILAC: N; Biosample/Treatment: ST-33-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

100

(2009) CST Curation Set: 8334; Year: 2009; SILAC: N; Biosample/Treatment: ST-7-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

101

(2009) CST Curation Set: 8320; Year: 2009; SILAC: N; Biosample/Treatment: ST-19-C(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

102

(2009) CST Curation Set: 8316; Year: 2009; SILAC: N; Biosample/Treatment: ST-7-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

103

(2009) CST Curation Set: 8319; Year: 2009; SILAC: N; Biosample/Treatment: ST-19-C(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

104

(2009) CST Curation Set: 8315; Year: 2009; SILAC: N; Biosample/Treatment: ST-7-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

105

(2009) CST Curation Set: 8317; Year: 2009; SILAC: N; Biosample/Treatment: ST-8-C(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

106

(2009) CST Curation Set: 8309; Year: 2009; SILAC: N; Biosample/Treatment: ST-33-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

107

(2009) CST Curation Set: 8312; Year: 2009; SILAC: N; Biosample/Treatment: ST-13-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

108

(2009) CST Curation Set: 8311; Year: 2009; SILAC: N; Biosample/Treatment: ST-13-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

109

(2009) CST Curation Set: 8314; Year: 2009; SILAC: N; Biosample/Treatment: ST-25-C(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

110

(2009) CST Curation Set: 8310; Year: 2009; SILAC: N; Biosample/Treatment: ST-33-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

111

(2009) CST Curation Set: 8306; Year: 2009; SILAC: N; Biosample/Treatment: ST-19-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

112

(2009) CST Curation Set: 8302; Year: 2009; SILAC: N; Biosample/Treatment: ST-41-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

113

(2009) CST Curation Set: 8303; Year: 2009; SILAC: N; Biosample/Treatment: ST-13-BL(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

114

(2009) CST Curation Set: 8308; Year: 2009; SILAC: N; Biosample/Treatment: ST-33-BL(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

115

(2009) CST Curation Set: 8304; Year: 2009; SILAC: N; Biosample/Treatment: ST-13-BL(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

116

(2009) CST Curation Set: 8305; Year: 2009; SILAC: N; Biosample/Treatment: ST-19-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

117

(2009) CST Curation Set: 8301; Year: 2009; SILAC: N; Biosample/Treatment: ST-41-BR(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

118

(2009) CST Curation Set: 8307; Year: 2009; SILAC: N; Biosample/Treatment: ST-33-BL(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

119

(2009) CST Curation Set: 8284; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-8-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

120

(2009) CST Curation Set: 8283; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-14-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

121

(2009) CST Curation Set: 8280; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-34-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

122

(2009) CST Curation Set: 8281; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-34-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

123

(2009) CST Curation Set: 8282; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-14-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

124

(2009) CST Curation Set: 8279; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-26-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

125

(2009) CST Curation Set: 8278; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-26-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

126

(2009) CST Curation Set: 8274; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-14-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

127

(2009) CST Curation Set: 8277; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-20-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

128

(2009) CST Curation Set: 8276; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-20-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

129

(2009) CST Curation Set: 8272; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-26-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

130

(2009) CST Curation Set: 8273; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-26-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

131

(2009) CST Curation Set: 8268; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-8-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

132

(2009) CST Curation Set: 8270; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-41-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

133

(2009) CST Curation Set: 8271; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-41-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

134

(2009) CST Curation Set: 8263; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-20-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

135

(2009) CST Curation Set: 8269; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-8-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

136

(2009) CST Curation Set: 8261; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-41-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

137

(2009) CST Curation Set: 8265; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-14-BL(tissue)/ischemia; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

138

(2009) CST Curation Set: 8264; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-14-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

139

(2009) CST Curation Set: 8258; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-25-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

140

(2009) CST Curation Set: 8260; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-41-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

141

(2009) CST Curation Set: 8259; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-25-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

142

(2009) CST Curation Set: 8250; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-34-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

143

(2009) CST Curation Set: 8257; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-13-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

144

(2009) CST Curation Set: 8256; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-13-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

145

(2009) CST Curation Set: 8254; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-20-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

146

(2009) CST Curation Set: 8251; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-34-BR(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

147

(2009) CST Curation Set: 8253; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-26-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

148

(2009) CST Curation Set: 8255; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-20-C(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

149

(2009) CST Curation Set: 8252; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-26-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

150

(2009) CST Curation Set: 8249; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-34-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

151

(2009) CST Curation Set: 8248; Year: 2009; SILAC: N; Biosample/Treatment: XY2-ST-34-BL(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

152

(2009) CST Curation Set: 7253; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

153

(2009) CST Curation Set: 7256; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

154

(2009) CST Curation Set: 7255; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

155

(2009) CST Curation Set: 7254; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

156

(2009) CST Curation Set: 7251; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

157

(2009) CST Curation Set: 7257; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

158

(2009) CST Curation Set: 7252; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

159

(2009) CST Curation Set: 7249; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

160

(2009) CST Curation Set: 7240; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

161

(2009) CST Curation Set: 7239; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

162

(2009) CST Curation Set: 7245; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

163

(2009) CST Curation Set: 7238; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

164

(2009) CST Curation Set: 7244; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

165

(2009) CST Curation Set: 7247; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

166

(2009) CST Curation Set: 7242; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

167

(2009) CST Curation Set: 7248; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

168

(2009) CST Curation Set: 7243; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

169

(2009) CST Curation Set: 7250; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

170

(2009) CST Curation Set: 7246; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

171

(2009) CST Curation Set: 7241; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

172

(2009) CST Curation Set: 7235; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

173

(2009) CST Curation Set: 7237; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

174

(2009) CST Curation Set: 7234; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

175

(2009) CST Curation Set: 7236; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

176

Sacco F, et al. (2009) Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases. J Biol Chem 284, 22048-58
19494114   Curated Info

177

Kwon H, Jeong K, Pak Y (2009) Identification of pY19-caveolin-2 as a positive regulator of insulin-stimulated actin cytoskeleton-dependent mitogenesis. J Cell Mol Med 13, 1549-64
19778377   Curated Info

178

Chaïb-Oukadour I, et al. (2009) Tetanus toxin H(C) fragment reduces neuronal MPP+ toxicity. Mol Cell Neurosci 41, 297-303
19344769   Curated Info

179

Kwon H, et al. (2009) Caveolin-2 regulation of STAT3 transcriptional activation in response to insulin. Biochim Biophys Acta 1793, 1325-33
19427337   Curated Info

180

(2009) CST Curation Set: 7162; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

181

(2009) CST Curation Set: 7165; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

182

(2009) CST Curation Set: 7137; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

183

(2009) CST Curation Set: 7164; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

184

(2009) CST Curation Set: 7163; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

185

(2009) CST Curation Set: 7151; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

186

(2009) CST Curation Set: 7149; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

187

(2009) CST Curation Set: 7152; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

188

(2009) CST Curation Set: 7148; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

189

(2009) CST Curation Set: 7153; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

190

(2009) CST Curation Set: 7150; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

191

(2009) CST Curation Set: 7141; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

192

(2009) CST Curation Set: 7144; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

193

(2009) CST Curation Set: 7140; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

194

(2009) CST Curation Set: 7145; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

195

(2009) CST Curation Set: 7146; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

196

(2009) CST Curation Set: 7147; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

197

(2009) CST Curation Set: 7142; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

198

(2009) CST Curation Set: 7139; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

199

(2009) CST Curation Set: 7143; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

200

(2009) CST Curation Set: 7138; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

201

(2009) CST Curation Set: 7132; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

202

(2009) CST Curation Set: 7135; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

203

(2009) CST Curation Set: 6804; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

204

(2009) CST Curation Set: 6805; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

205

(2009) CST Curation Set: 6797; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

206

(2009) CST Curation Set: 6802; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

207

(2009) CST Curation Set: 6803; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

208

(2009) CST Curation Set: 6807; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

209

(2009) CST Curation Set: 6796; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

210

(2009) CST Curation Set: 6801; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

211

(2009) CST Curation Set: 6787; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

212

(2009) CST Curation Set: 6793; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

213

(2009) CST Curation Set: 6789; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

214

(2009) CST Curation Set: 6794; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

215

(2009) CST Curation Set: 6788; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

216

(2009) CST Curation Set: 6781; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

217

(2009) CST Curation Set: 6786; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

218

(2009) CST Curation Set: 6785; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

219

(2009) CST Curation Set: 6775; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

220

(2009) CST Curation Set: 6780; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

221

(2009) CST Curation Set: 6770; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

222

(2009) CST Curation Set: 6771; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

223

(2009) CST Curation Set: 6779; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

224

(2009) CST Curation Set: 6769; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

225

(2009) CST Curation Set: 6768; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

226

(2009) CST Curation Set: 6767; Year: 2009; SILAC: N; Biosample/Treatment: esophagus(tissue)/untreated; Disease: ischemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

227

Lee DI, et al. (2009) Activation of (Na+ + K+)-ATPase modulates cardiac L-type Ca2+ channel function. Mol Pharmacol 75, 774-81
19122004   Curated Info

228

Togo K, et al. (2009) Aspirin and salicylates modulate IgE-mediated leukotriene secretion in mast cells through a dihydropyridine receptor-mediated Ca(2+) influx. Clin Immunol 131, 145-56
19144570   Curated Info

229

Edwards S, Graham DL, Whisler KN, Self DW (2009) Phosphorylation of GluR1, ERK, and CREB during spontaneous withdrawal from chronic heroin self-administration. Synapse 63, 224-35
19084907   Curated Info

230

Feldman ME, et al. (2009) Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol 7, e38
19209957   Curated Info

231

(2009) CST Curation Set: 5871; Year: 2009; SILAC: N; Biosample/Treatment: brain(tissue)/No seizure; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

232

(2009) CST Curation Set: 5870; Year: 2009; SILAC: N; Biosample/Treatment: brain(tissue)/No seizure; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

233

(2009) CST Curation Set: 5868; Year: 2009; SILAC: N; Biosample/Treatment: brain(tissue)/No seizure; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

234

(2009) CST Curation Set: 5869; Year: 2009; SILAC: N; Biosample/Treatment: brain(tissue)/No seizure; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

235

(2009) CST Curation Set: 5862; Year: 2009; SILAC: N; Biosample/Treatment: brain(tissue)/sham; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

236

(2009) CST Curation Set: 5864; Year: 2009; SILAC: N; Biosample/Treatment: brain(tissue)/seizure; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

237

(2009) CST Curation Set: 5865; Year: 2009; SILAC: N; Biosample/Treatment: brain(tissue)/seizure; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

238

(2009) CST Curation Set: 5866; Year: 2009; SILAC: N; Biosample/Treatment: brain(tissue)/seizure; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

239

(2009) CST Curation Set: 5861; Year: 2009; SILAC: N; Biosample/Treatment: brain(tissue)/sham; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

240

(2009) CST Curation Set: 5860; Year: 2009; SILAC: N; Biosample/Treatment: brain(tissue)/sham; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

241

Doggen K, et al. (2009) Ventricular ErbB2/ErbB4 activation and downstream signaling in pacing-induced heart failure. J Mol Cell Cardiol 46, 33-8
19010331   Curated Info

242

Lorenz K, Schmitt JP, Schmitteckert EM, Lohse MJ (2009) A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy. Nat Med 15, 75-83
19060905   Curated Info

243

Tian HP, et al. (2009) Non-receptor tyrosine kinase Src is required for ischemia-stimulated neuronal cell proliferation via Raf/ERK/CREB activation in the dentate gyrus. BMC Neurosci 10, 139
19943942   Curated Info

244

Philippar U, et al. (2008) A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev Cell 15, 813-28
19081071   Curated Info

245

Marin TM, et al. (2008) Shp2 negatively regulates growth in cardiomyocytes by controlling focal adhesion kinase/Src and mTOR pathways. Circ Res 103, 813-24
18757826   Curated Info

246

(2008) CST Curation Set: 5263; Year: 2008; SILAC: N; Biosample/Treatment: PC-12(cell line)/untreated; Disease: pheochromocytoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

247

(2008) CST Curation Set: 5265; Year: 2008; SILAC: N; Biosample/Treatment: PC-12(cell line)/PACAP; Disease: pheochromocytoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

248

(2008) CST Curation Set: 5266; Year: 2008; SILAC: N; Biosample/Treatment: PC-12(cell line)/PACAP; Disease: pheochromocytoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

249

(2008) CST Curation Set: 5267; Year: 2008; SILAC: N; Biosample/Treatment: PC-12(cell line)/PACAP; Disease: pheochromocytoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

250

(2008) CST Curation Set: 5268; Year: 2008; SILAC: N; Biosample/Treatment: PC-12(cell line)/PACAP; Disease: pheochromocytoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

251

(2008) CST Curation Set: 5216; Year: 2008; SILAC: N; Biosample/Treatment: brain(tissue)/mock surgery; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

252

(2008) CST Curation Set: 5217; Year: 2008; SILAC: N; Biosample/Treatment: brain(tissue)/mock surgery; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

253

(2008) CST Curation Set: 5218; Year: 2008; SILAC: N; Biosample/Treatment: brain(tissue)/mock surgery; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

254

(2008) CST Curation Set: 5219; Year: 2008; SILAC: N; Biosample/Treatment: brain(tissue)/ischemia; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

255

(2008) CST Curation Set: 5221; Year: 2008; SILAC: N; Biosample/Treatment: brain(tissue)/ischemia; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

256

(2008) CST Curation Set: 5222; Year: 2008; SILAC: N; Biosample/Treatment: brain(tissue)/ischemia; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

257

(2008) CST Curation Set: 5204; Year: 2008; SILAC: N; Biosample/Treatment: PC-12(cell line)/NGF; Disease: pheochromocytoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

258

Lomonaco SL, et al. (2008) Phosphorylation of protein kinase Cdelta on distinct tyrosine residues induces sustained activation of Erk1/2 via down-regulation of MKP-1: role in the apoptotic effect of etoposide. J Biol Chem 283, 17731-9
18434324   Curated Info

259

Ozgen N, et al. (2008) Protein kinase D links Gq-coupled receptors to cAMP response element-binding protein (CREB)-Ser133 phosphorylation in the heart. J Biol Chem 283, 17009-19
18378685   Curated Info

260

Gopalakrishna R, Gundimeda U, Schiffman JE, McNeill TH (2008) A direct redox regulation of protein kinase C isoenzymes mediates oxidant-induced neuritogenesis in PC12 cells. J Biol Chem 283, 14430-44
18375950   Curated Info

261

(2008) CST Curation Set: 4008; Year: 2008; SILAC: N; Biosample/Treatment: PC-12(cell line)/untreated; Disease: pheochromocytoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

262

(2008) CST Curation Set: 4009; Year: 2008; SILAC: N; Biosample/Treatment: PC-12(cell line)/EGF; Disease: pheochromocytoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

263

(2008) CST Curation Set: 4012; Year: 2008; SILAC: N; Biosample/Treatment: PC-12(cell line)/untreated; Disease: pheochromocytoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

264

(2008) CST Curation Set: 4013; Year: 2008; SILAC: N; Biosample/Treatment: PC-12(cell line)/PACAP; Disease: pheochromocytoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

265

Fujita T, Ryser S, Piuz I, Schlegel W (2008) Up-regulation of P-TEFb by the MEK1-extracellular signal-regulated kinase signaling pathway contributes to stimulated transcription elongation of immediate early genes in neuroendocrine cells. Mol Cell Biol 28, 1630-43
18086894   Curated Info

266

Samarakoon R, Higgins SP, Higgins CE, Higgins PJ (2008) TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling. J Mol Cell Cardiol 44, 527-38
18255094   Curated Info

267

(2008) CST Curation Set: 3877; Year: 2008; SILAC: N; Biosample/Treatment: PC-12(cell line)/untreated; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

268

(2008) CST Curation Set: 3879; Year: 2008; SILAC: N; Biosample/Treatment: PC-12(cell line)/untreated; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

269

(2008) CST Curation Set: 3880; Year: 2008; SILAC: N; Biosample/Treatment: PC-12(cell line)/NGF; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

270

(2007) CST Curation Set: 3591; Year: 2007; SILAC: N; Biosample/Treatment: PC-12(cell line)/NGF; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

271

(2007) CST Curation Set: 3592; Year: 2007; SILAC: N; Biosample/Treatment: PC-12(cell line)/untreated; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

272

(2007) CST Curation Set: 3593; Year: 2007; SILAC: N; Biosample/Treatment: PC-12(cell line)/NGF; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

273

(2007) CST Curation Set: 3595; Year: 2007; SILAC: N; Biosample/Treatment: PC-12(cell line)/NGF; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

274

(2007) CST Curation Set: 3590; Year: 2007; SILAC: N; Biosample/Treatment: PC-12(cell line)/untreated; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

275

Li J, et al. (2007) The pro-angiogenic cytokine pleiotrophin potentiates cardiomyocyte apoptosis through inhibition of endogenous AKT/PKB activity. J Biol Chem 282, 34984-93
17925408   Curated Info

276

(2007) CST Curation Set: 3524; Year: 2007; SILAC: N; Biosample/Treatment: PC-12(cell line)/NGF; Disease: pheochromocytoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

277

(2007) CST Curation Set: 3525; Year: 2007; SILAC: N; Biosample/Treatment: PC-12(cell line)/NGF; Disease: pheochromocytoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

278

(2007) CST Curation Set: 3522; Year: 2007; SILAC: N; Biosample/Treatment: PC-12(cell line)/untreated; Disease: pheochromocytoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

279

(2007) CST Curation Set: 3523; Year: 2007; SILAC: N; Biosample/Treatment: PC-12(cell line)/untreated; Disease: pheochromocytoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

280

Xu K, Kitchen CM, Shu HK, Murphy TJ (2007) Platelet-derived Growth Factor-induced Stabilization of Cyclooxygenase 2 mRNA in Rat Smooth Muscle Cells Requires the c-Src Family of Protein-tyrosine Kinases. J Biol Chem 282, 32699-709
17855367   Curated Info

281

Senyo SE, Koshman YE, Russell B (2007) Stimulus interval, rate and direction differentially regulate phosphorylation for mechanotransduction in neonatal cardiac myocytes. FEBS Lett 581, 4241-7
17698065   Curated Info

282

Giraud J, et al. (2007) Phosphorylation of Irs1 at SER-522 inhibits insulin signaling. Mol Endocrinol 21, 2294-302
17579213   Curated Info

283

Ballou LM, et al. (2007) Inhibition of mammalian target of rapamycin signaling by 2-(morpholin-1-yl)pyrimido[2,1-alpha]isoquinolin-4-one. J Biol Chem 282, 24463-70
17562705   Curated Info

284

Oh MA, et al. (2007) PKCdelta and cofilin activation affects peripheral actin reorganization and cell-cell contact in cells expressing integrin alpha5 but not its tailless mutant. J Cell Sci 120, 2717-30
17646675   Curated Info

285

Park ER, Eblen ST, Catling AD (2007) MEK1 activation by PAK: a novel mechanism. Cell Signal 19, 1488-96
17314031   Curated Info

286

Jaubert AM, et al. (2007) Nongenomic estrogen effects on nitric oxide synthase activity in rat adipocytes. Endocrinology 148, 2444-52
17303666   Curated Info

287

Jiang X, Sinnett-Smith J, Rozengurt E (2007) Differential FAK phosphorylation at Ser-910, Ser-843 and Tyr-397 induced by angiotensin II, LPA and EGF in intestinal epithelial cells. Cell Signal 19, 1000-10
17240116   Curated Info

288

Berna MJ, et al. (2007) CCK causes PKD1 activation in pancreatic acini by signaling through PKC-delta and PKC-independent pathways. Biochim Biophys Acta 1773, 483-501
17306383   Curated Info

289

Liang MH, Chuang DM (2007) Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival. J Biol Chem 282, 3904-17
17148450   Curated Info

290

Saraf A, Virshup DM, Strack S (2007) Differential expression of the B'beta regulatory subunit of protein phosphatase 2A modulates tyrosine hydroxylase phosphorylation and catecholamine synthesis. J Biol Chem 282, 573-80
17085438   Curated Info

291

Nascimento EB, et al. (2006) Insulin-mediated phosphorylation of the proline-rich Akt substrate PRAS40 is impaired in insulin target tissues of high-fat diet-fed rats. Diabetes 55, 3221-8
17130464   Curated Info

292

Xu S, Bayat H, Hou X, Jiang B (2006) Ribosomal S6 kinase-1 modulates interleukin-1beta-induced persistent activation of NF-kappaB through phosphorylation of IkappaBbeta. Am J Physiol Cell Physiol 291, C1336-45
16822942   Curated Info

293

Pellegrino MJ, Stork PJ (2006) Sustained activation of extracellular signal-regulated kinase by nerve growth factor regulates c-fos protein stabilization and transactivation in PC12 cells. J Neurochem 99, 1480-93
17223854   Curated Info

294

Nomiyama T, et al. (2006) The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation. J Biol Chem 281, 33467-76
16945922   Curated Info

295

Deinhardt K, et al. (2006) Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron 52, 293-305
17046692   Curated Info

296

Quiroz C, et al. (2006) Blockade of adenosine A2A receptors prevents protein phosphorylation in the striatum induced by cortical stimulation. J Neurosci 26, 10808-12
17050719   Curated Info

297

Hashimoto R, et al. (2006) Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum Mol Genet 15, 3024-33
16959794   Curated Info

298

Fu Q, et al. (2006) Growth retardation alters the epigenetic characteristics of hepatic dual specificity phosphatase 5. FASEB J 20, 2127-9
16940436   Curated Info

299

Beard KM, Lu H, Ho K, Fantus IG (2006) Bradykinin augments insulin-stimulated glucose transport in rat adipocytes via endothelial nitric oxide synthase-mediated inhibition of Jun NH2-terminal kinase. Diabetes 55, 2678-87
17003331   Curated Info

300

Page G, et al. (2006) Group I metabotropic glutamate receptors activate the p70S6 kinase via both mammalian target of rapamycin (mTOR) and extracellular signal-regulated kinase (ERK 1/2) signaling pathways in rat striatal and hippocampal synaptoneurosomes. Neurochem Int 49, 413-21
16549223   Curated Info

301

Chen L, et al. (2006) Peroxisome proliferator-activated receptor gamma promotes epithelial to mesenchymal transformation by Rho GTPase-dependent activation of ERK1/2. J Biol Chem 281, 24575-87
16815847   Curated Info

302

Jin H, Sperka T, Herrlich P, Morrison H (2006) Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase. Nature 442, 576-9
16885985   Curated Info

303

Bhattacharya S, Ray RM, Johnson LR (2006) Integrin beta3-mediated Src activation regulates apoptosis in IEC-6 cells via Akt and STAT3. Biochem J 397, 437-47
16669788   Curated Info

304

Samuelsson AM, et al. (2006) Hyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways. Am J Physiol Heart Circ Physiol 291, H787-96
16565309   Curated Info

305

Obreztchikova M, et al. (2006) Distinct signaling functions for Shc isoforms in the heart. J Biol Chem 281, 20197-204
16699171   Curated Info

306

Ng YP, Cheung ZH, Ip NY (2006) STAT3 as a downstream mediator of Trk signaling and functions. J Biol Chem 281, 15636-44
16611639   Curated Info

307

Douillette A, et al. (2006) The proinflammatory actions of angiotensin II are dependent on p65 phosphorylation by the IkappaB kinase complex. J Biol Chem 281, 13275-84
16513650   Curated Info

308

Hoffert JD, et al. (2006) Quantitative phosphoproteomics of vasopressin-sensitive renal cells: regulation of aquaporin-2 phosphorylation at two sites. Proc Natl Acad Sci U S A 103, 7159-64
16641100   Curated Info

309

Easton JB, Royer AR, Middlemas DS (2006) The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor. J Neurochem 97, 834-45
16573649   Curated Info

310

Morii H, et al. (2006) Site-specific phosphorylation of SCG10 in neuronal plasticity: role of Ser73 phosphorylation by N-methyl D-aspartic acid receptor activation in rat hippocampus. Neurosci Lett 396, 241-6
16368189   Curated Info

311

Ohi N, et al. (2006) Maintenance of Bad phosphorylation prevents apoptosis of rat hepatic sinusoidal endothelial cells in vitro and in vivo. Am J Pathol 168, 1097-106
16565486   Curated Info

312

Tzatsos A, Kandror KV (2006) Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol Cell Biol 26, 63-76
16354680   Curated Info

313

Kim JH, et al. (2006) Overexpression of calbindin-D28K in hippocampal progenitor cells increases neuronal differentiation and neurite outgrowth. FASEB J 20, 109-11
16278289   Curated Info

314

Fassett J, Tobolt D, Hansen LK (2006) Type I collagen structure regulates cell morphology and EGF signaling in primary rat hepatocytes through cAMP-dependent protein kinase A. Mol Biol Cell 17, 345-56
16251347   Curated Info

315

Chung D, Loch Caruso R (2005) 2,2'-Dichlorobiphenyl decreases amplitude and synchronization of uterine contractions through MAPK1-mediated phosphorylation of GJA1 (connexin43) and inhibition of myometrial gap junctions. Biol Reprod 73, 974-82
16000550   Curated Info

316

Tosca L, et al. (2005) Adenosine 5'-monophosphate-activated protein kinase regulates progesterone secretion in rat granulosa cells. Endocrinology 146, 4500-13
16020477   Curated Info

317

Pinzar E, et al. (2005) Angiotensin II induces tyrosine nitration and activation of ERK1/2 in vascular smooth muscle cells. FEBS Lett 579, 5100-4
16139272   Curated Info

318

Cybulsky AV, et al. (2005) Activation of the extracellular signal-regulated kinase by complement C5b-9. Am J Physiol Renal Physiol 289, F593-603
15855657   Curated Info

319

Liu R, et al. (2005) Acute anoxia induces tau dephosphorylation in rat brain slices and its possible underlying mechanisms. J Neurochem 94, 1225-34
15992372   Curated Info

320

Zhu Y, et al. (2005) Rap2-JNK removes synaptic AMPA receptors during depotentiation. Neuron 46, 905-16
15953419   Curated Info

321

Hers I, Tavaré JM (2005) Mechanism of feedback regulation of insulin receptor substrate-1 phosphorylation in primary adipocytes. Biochem J 388, 713-20
15713122   Curated Info

322

Azoitei N, Wirth T, Baumann B (2005) Activation of the IkappaB kinase complex is sufficient for neuronal differentiation of PC12 cells. J Neurochem 93, 1487-501
15935065   Curated Info

323

(2005) CST Curation Set: 678; Year: 2005; SILAC: N; Biosample/Treatment: brain(tissue)/-; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

324

(2005) CST Curation Set: 679; Year: 2005; SILAC: N; Biosample/Treatment: brain(tissue)/ischemia 15'; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

325

(2005) CST Curation Set: 680; Year: 2005; SILAC: N; Biosample/Treatment: brain(tissue)/ischemia 20'; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

326

Mao L, et al. (2005) Role of protein phosphatase 2A in mGluR5-regulated MEK/ERK phosphorylation in neurons. J Biol Chem 280, 12602-10
15661743   Curated Info

327

Dallabrida SM, et al. (2005) Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins. Circ Res 96, e8-24
15692086   Curated Info

328

Abdelmohsen K, et al. (2005) Doxorubicin induces EGF receptor-dependent downregulation of gap junctional intercellular communication in rat liver epithelial cells. Biol Chem 386, 217-23
15843167   Curated Info

329

Lee B, et al. (2005) Activity-dependent neuroprotection and cAMP response element-binding protein (CREB): kinase coupling, stimulus intensity, and temporal regulation of CREB phosphorylation at serine 133. J Neurosci 25, 1137-48
15689550   Curated Info

330

(2005) CST Curation Set: 531; Year: 2005; SILAC: N; Biosample/Treatment: brain(tissue)/normal; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

331

(2005) CST Curation Set: 522; Year: 2005; SILAC: N; Biosample/Treatment: brain(tissue)/ischemia; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

332

Corvol JC, et al. (2005) Depolarization activates ERK and proline-rich tyrosine kinase 2 (PYK2) independently in different cellular compartments in hippocampal slices. J Biol Chem 280, 660-8
15537634   Curated Info

333

Hekerman P, et al. (2005) Pleiotropy of leptin receptor signalling is defined by distinct roles of the intracellular tyrosines. FEBS J 272, 109-19
15634336   Curated Info

334

Obara Y, Labudda K, Dillon TJ, Stork PJ (2004) PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells. J Cell Sci 117, 6085-94
15546918   Curated Info

335

Ma Y, et al. (2004) Mechanisms of hemorrhage-induced hepatic insulin resistance: role of tumor necrosis factor-alpha. Endocrinology 145, 5168-76
15297437   Curated Info

336

Mifune M, et al. (2004) Signal transduction of betacellulin in growth and migration of vascular smooth muscle cells. Am J Physiol Cell Physiol 287, C807-13
15163624   Curated Info

337

Boutahar N, Guignandon A, Vico L, Lafage-Proust MH (2004) Mechanical strain on osteoblasts activates autophosphorylation of focal adhesion kinase and proline-rich tyrosine kinase 2 tyrosine sites involved in ERK activation. J Biol Chem 279, 30588-99
15096502   Curated Info

338

Andreozzi F, et al. (2004) Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells. Endocrinology 145, 2845-57
15001544   Curated Info

339

Sabio G, et al. (2004) Stress- and mitogen-induced phosphorylation of the synapse-associated protein SAP90/PSD-95 by activation of SAPK3/p38gamma and ERK1/ERK2. Biochem J 380, 19-30
14741046   Curated Info

340

de Alvaro C, Teruel T, Hernandez R, Lorenzo M (2004) Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem 279, 17070-8
14764603   Curated Info

341

Jiang G, et al. (2004) Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo. Biochem J 377, 339-46
14556646   Curated Info

342

Gardner OS, et al. (2003) Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation. J Biol Chem 278, 46261-9
12966092   Curated Info

343

Berken A, Abel J, Unfried K (2003) beta1-integrin mediates asbestos-induced phosphorylation of AKT and ERK1/2 in a rat pleural mesothelial cell line. Oncogene 22, 8524-8
14627993   Curated Info

344

Hilder TL, et al. (2003) Phosphorylation of insulin receptor substrate-1 serine 307 correlates with JNK activity in atrophic skeletal muscle. FEBS Lett 553, 63-7
14550547   Curated Info

345

Slack-Davis JK, et al. (2003) PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation. J Cell Biol 162, 281-91
12876277   Curated Info

346

Fujimoto TT, Katsutani S, Shimomura T, Fujimura K (2003) Thrombospondin-bound integrin-associated protein (CD47) physically and functionally modifies integrin alphaIIbbeta3 by its extracellular domain. J Biol Chem 278, 26655-65
12736272   Curated Info

347

Yang YC, et al. (2003) Focal adhesion kinase is required, but not sufficient, for the induction of long-term potentiation in dentate gyrus neurons in vivo. J Neurosci 23, 4072-80
12764094   Curated Info

348

Haider UG, et al. (2003) Resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells. Mol Pharmacol 63, 925-32
12644594   Curated Info

349

Greene MW, et al. (2003) Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by Serine 312 phosphorylation. J Biol Chem 278, 8199-211
12510059   Curated Info

350

Ehlers MD (2003) Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat Neurosci 6, 231-42
12577062   Curated Info

351

Kitta K, et al. (2003) Hepatocyte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells. J Biol Chem 278, 4705-12
12468531   Curated Info

352

Sakamoto H, Tosaki T, Nakagawa Y (2002) Overexpression of phospholipid hydroperoxide glutathione peroxidase modulates acetyl-CoA, 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine acetyltransferase activity. J Biol Chem 277, 50431-8
12397078   Curated Info

353

Wrede CE, et al. (2002) Protein kinase B/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1). J Biol Chem 277, 49676-84
12393870   Curated Info

354

Clerk A, et al. (2002) Up-regulation of c-jun mRNA in cardiac myocytes requires the extracellular signal-regulated kinase cascade, but c-Jun N-terminal kinases are required for efficient up-regulation of c-Jun protein. Biochem J 368, 101-10
12169099   Curated Info

355

Sometani A, et al. (2002) 4-Methylcatechol stimulates phosphorylation of Trk family neurotrophin receptors and MAP kinases in cultured rat cortical neurons. J Neurosci Res 70, 335-9
12391593   Curated Info

356

Han JM, et al. (2002) Localization of phospholipase D1 to caveolin-enriched membrane via palmitoylation: implications for epidermal growth factor signaling. Mol Biol Cell 13, 3976-88
12429840   Curated Info

357

Kumar V, Frost RA, Lang CH (2002) Alcohol impairs insulin and IGF-I stimulation of S6K1 but not 4E-BP1 in skeletal muscle. Am J Physiol Endocrinol Metab 283, E917-28
12376318   Curated Info

358

Cheng HC, Shih HM, Chern Y (2002) Essential role of cAMP-response element-binding protein activation by A2A adenosine receptors in rescuing the nerve growth factor-induced neurite outgrowth impaired by blockage of the MAPK cascade. J Biol Chem 277, 33930-42
12114502   Curated Info

359

Kato K, et al. (2002) Innervation-dependent phosphorylation and accumulation of alphaB-crystallin and Hsp27 as insoluble complexes in disused muscle. FASEB J 16, 1432-4
12205038   Curated Info

360

Buschbeck M, Eickhoff J, Sommer MN, Ullrich A (2002) Phosphotyrosine-specific phosphatase PTP-SL regulates the ERK5 signaling pathway. J Biol Chem 277, 29503-9
12042304   Curated Info

361

Swarthout JT, et al. (2002) Induction of transcriptional activity of the cyclic adenosine monophosphate response element binding protein by parathyroid hormone and epidermal growth factor in osteoblastic cells. J Bone Miner Res 17, 1401-7
12162494   Curated Info

362

Obrietan K, Gao XB, Van Den Pol AN (2002) Excitatory actions of GABA increase BDNF expression via a MAPK-CREB-dependent mechanism--a positive feedback circuit in developing neurons. J Neurophysiol 88, 1005-15
12163549   Curated Info

363

Zhu Y, et al. (2002) Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J Neurosci 22, 3898-909
12019309   Curated Info

364

Dagø L, et al. (2002) NS 1231, a novel compound with neurotrophic-like effects in vitro and in vivo. J Neurochem 81, 17-24
12067229   Curated Info

365

Lingohr MK, et al. (2002) Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation. Diabetes 51, 966-76
11916914   Curated Info

366

Stocco CO, Lau LF, Gibori G (2002) A calcium/calmodulin-dependent activation of ERK1/2 mediates JunD phosphorylation and induction of nur77 and 20alpha-hsd genes by prostaglandin F2alpha in ovarian cells. J Biol Chem 277, 3293-302
11719525   Curated Info

367

Motley ED, et al. (2002) Lysophosphatidylcholine inhibits insulin-induced Akt activation through protein kinase C-alpha in vascular smooth muscle cells. Hypertension 39, 508-12
11882599   Curated Info

368

Reusch HP, et al. (2001) Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells. J Biol Chem 276, 33630-7
11443134   Curated Info

369

Sheng H, Shao J, Dubois RN (2001) K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. Cancer Res 61, 2670-5
11289146   Curated Info

370

Qian X, Ginty DD (2001) SH2-B and APS are multimeric adapters that augment TrkA signaling. Mol Cell Biol 21, 1613-20
11238898   Curated Info

371

Djouder N, et al. (2001) Rac and phosphatidylinositol 3-kinase regulate the protein kinase B in Fc epsilon RI signaling in RBL 2H3 mast cells. J Immunol 166, 1627-34
11160204   Curated Info

372

Li PA, et al. (2001) Phosphorylation of extracellular signal-regulated kinase after transient cerebral ischemia in hyperglycemic rats. Neurobiol Dis 8, 127-35
11162246   Curated Info

373

Shen H, Tong L, Balazs R, Cotman CW (2001) Physical activity elicits sustained activation of the cyclic AMP response element-binding protein and mitogen-activated protein kinase in the rat hippocampus. Neuroscience 107, 219-29
11731096   Curated Info

374

Hauck CR, Hsia DA, Schlaepfer DD (2000) Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells. J Biol Chem 275, 41092-9
10998418   Curated Info

375

Blanchard F, et al. (2000) Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase. J Biol Chem 275, 28793-801
10858440   Curated Info

376

Haas M, Askari A, Xie Z (2000) Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase. J Biol Chem 275, 27832-7
10874030   Curated Info

377

Sala C, Rudolph-Correia S, Sheng M (2000) Developmentally regulated NMDA receptor-dependent dephosphorylation of cAMP response element-binding protein (CREB) in hippocampal neurons. J Neurosci 20, 3529-36
10804193   Curated Info

378

Sada K, Zhang J, Siraganian RP (2000) Point mutation of a tyrosine in the linker region of Syk results in a gain of function. J Immunol 164, 338-44
10605028   Curated Info

379

Xu B, Wilsbacher JL, Collisson T, Cobb MH (1999) The N-terminal ERK-binding site of MEK1 is required for efficient feedback phosphorylation by ERK2 in vitro and ERK activation in vivo. J Biol Chem 274, 34029-35
10567369   Curated Info

380

Cybulsky AV, Takano T, Papillon J, McTavish AJ (1999) Complement C5b-9 induces receptor tyrosine kinase transactivation in glomerular epithelial cells. Am J Pathol 155, 1701-11
10550326   Curated Info

381

Iwasaki S, et al. (1999) Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC12 cells by bone morphogenetic protein-2. J Biol Chem 274, 26503-10
10473611   Curated Info

382

Conrad PW, et al. (1999) Selective activation of p38alpha and p38gamma by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells. J Biol Chem 274, 23570-6
10438538   Curated Info

383

Lowe M, et al. (1998) Cdc2 kinase directly phosphorylates the cis-Golgi matrix protein GM130 and is required for Golgi fragmentation in mitosis. Cell 94, 783-93
9753325   Curated Info

384

Xing J, et al. (1998) Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol Cell Biol 18, 1946-55
9528766   Curated Info

385

Robbins DJ, et al. (1993) Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. J Biol Chem 268, 5097-106
8444886   Curated Info

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.